Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 30 Mar 2026 for LENZ Therapeutics, Inc., €218k. Read the official filing
Filing timeline
BuySaleEvert B. Schimmelpennink
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -37.0%Entry US$9.15 · Close at T+90 US$5.76
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Evert B. Schimmelpennink: trading record in brief
All filings by Evert B. Schimmelpennink on record concern LENZ Therapeutics, Inc. The record holds 3 filings, for trades running from 22 July 2024 to 27 March 2026.
On the market, this insider has only ever bought: 1 purchase, €218k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 option exercises. So far in 2026, the count stands at 1 purchase and no sales.
The record was last updated on 30 March 2026 with an open-market purchase (€218k) in LENZ Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Evert B. Schimmelpennink
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
28,089 shares@ US$8.950582.3% of flowCommon StockSEC:0001713795-26-000004:0
Canonical exit: 25 Jun 2026 (T+90)
4,200 shares@ US$1.041.5% of flowCommon StockSEC:0001815776-25-000011:0
45,000 shares@ US$1.0416.2% of flowCommon StockSEC:0001815776-24-000051:0
3 of 3 declarations
